- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05167773
Clinical Study of the Topcon Tonometer TRK-3
July 19, 2022 updated by: Topcon Corporation
Clinical Study of the Topcon Tonometer TRK-3 to Demonstrate Conformance to ISO 8612, JIS T7312, and ANSI Z80.10-2014 Ophthalmic Instruments - Tonometers
The study will assess the TRK-3 for conformity to ISO 8612:2009, JIS T7312:2015, and ANSI Z80.10-2014 Ophthalmic Instruments - Tonometers, to the FDA Guidance for Industry and FDA Staff, Tonometer-Premarket Notification [510(k)] Submissions, and the applicable Supplemental Information Sheet.
Study Overview
Study Type
Observational
Enrollment (Actual)
139
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tokyo, Japan
- Kato Eye Clinic
-
Tokyo, Japan
- Seiyo Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subjects undergoing routine eye exam at eye care clinic
Description
Inclusion Criteria:
- Be 18 years of age or older at the time of informed consent
- Irrespective of sex
- Irrespective of race or ethnicity
- Be willing and able to provide written informed consent by subject or legally designated representative prior to any study procedures
Exclusion Criteria:
- Have only one functional eye
- Have one eye with poor or eccentric fixation
- Have corneal scarring or have had corneal surgery, including corneal laser surgery in either eye
- Have microphthalmos in either eye
- Have buphthalmos in either eye
- Be a contact lens wearer (persons wearing soft contact lenses within the past 3 months and/or hard contact lenses within the past 6 months)
- Have dry eyes (persons who have been diagnosed by a physician and are currently using prescription drugs or routinely using artificial tears)
- Uncontrollably blink, squint, wink, twitch or squeeze eye(s) - blepharospasm
- Have nystagmus in either eye
- Have keratoconus in either eye
- Have any other corneal or conjunctival pathology or infection in either eye
- Have central corneal thickness is less than 500μm or more than 600μm
- Be allergic to eye drop anesthetics
- Be allergic to sodium fluorescein
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
fluid pressure inside the eye (intraocular pressure) measured in millimeters of mercury (mm Hg)
Time Frame: 1 day
|
Intraocular Pressure (IOP) measurements acquired with the study tonometer are compared to the reference tonometer IOP measurements to demonstrate that they meet the requirement specified in the tonometer standards (ISO 8612:2009, JIS T7312:2015 and ANSI Z80.10-2014)
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 11, 2021
Primary Completion (ACTUAL)
January 14, 2022
Study Completion (ACTUAL)
January 14, 2022
Study Registration Dates
First Submitted
November 8, 2021
First Submitted That Met QC Criteria
December 21, 2021
First Posted (ACTUAL)
December 22, 2021
Study Record Updates
Last Update Posted (ACTUAL)
July 20, 2022
Last Update Submitted That Met QC Criteria
July 19, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- THQ-2021-04
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intraocular Pressure
-
University of PittsburghRecruiting
-
The University of Hong KongCompleted
-
Rajiv Gandhi Cancer Institute & Research Center...CompletedIntraocular PressureIndia
-
Prince of Songkla UniversityCompletedIntraocular PressureThailand
-
Astellas Pharma IncCompletedIntraocular PressureUnited States
-
First Affiliated Hospital, Sun Yat-Sen UniversityUnknown
-
Icare Finland OyCompleted
-
Iladevi Cataract and IOL Research CenterCompleted
Clinical Trials on tonometer
-
Intuor Technologies, Inc.Completed
-
Intuor Technologies, Inc.Completed
-
University of NebraskaCompletedIntraocular PressureUnited States
-
Intuor Technologies, Inc.Unknown
-
Barnes Retina InstituteUnknownElevated Intraocular PressureUnited States
-
NHS LothianUnknown
-
Comprehensive EyeCare of Central OhioIcare USACompletedEvaluation of Corneal Stability Post-applanationUnited States